| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3760989
[patent_doc_number] => 05843911
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Hyaluronidase inhibitor containing god-type ellagitannin as active ingredient'
[patent_app_type] => 1
[patent_app_number] => 8/600111
[patent_app_country] => US
[patent_app_date] => 1996-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4014
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843911.pdf
[firstpage_image] =>[orig_patent_app_number] => 600111
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/600111 | Hyaluronidase inhibitor containing god-type ellagitannin as active ingredient | Feb 11, 1996 | Issued |
Array
(
[id] => 3805932
[patent_doc_number] => 05830884
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Pharmaceutical products containing thermally-inhibited starches'
[patent_app_type] => 1
[patent_app_number] => 8/595008
[patent_app_country] => US
[patent_app_date] => 1996-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22662
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830884.pdf
[firstpage_image] =>[orig_patent_app_number] => 595008
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/595008 | Pharmaceutical products containing thermally-inhibited starches | Jan 30, 1996 | Issued |
Array
(
[id] => 3769965
[patent_doc_number] => 05733888
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-31
[patent_title] => 'Injectable composition'
[patent_app_type] => 1
[patent_app_number] => 8/594478
[patent_app_country] => US
[patent_app_date] => 1996-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1078
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/733/05733888.pdf
[firstpage_image] =>[orig_patent_app_number] => 594478
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/594478 | Injectable composition | Jan 30, 1996 | Issued |
Array
(
[id] => 3720578
[patent_doc_number] => 05681578
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-28
[patent_title] => 'Composition for relieving stress anxiety, grief, and depression'
[patent_app_type] => 1
[patent_app_number] => 8/589757
[patent_app_country] => US
[patent_app_date] => 1996-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1319
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/681/05681578.pdf
[firstpage_image] =>[orig_patent_app_number] => 589757
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/589757 | Composition for relieving stress anxiety, grief, and depression | Jan 21, 1996 | Issued |
| 08/537683 | PHARMACEUTICAL PREPARATIONS COMPRISING CYCLOSPORIN FOR ORAL ADMINISTRATION | Jan 21, 1996 | Abandoned |
Array
(
[id] => 3980616
[patent_doc_number] => 05948821
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-07
[patent_title] => 'Methods of using ajoene'
[patent_app_type] => 1
[patent_app_number] => 8/585190
[patent_app_country] => US
[patent_app_date] => 1996-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3768
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/948/05948821.pdf
[firstpage_image] =>[orig_patent_app_number] => 585190
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/585190 | Methods of using ajoene | Jan 10, 1996 | Issued |
Array
(
[id] => 4036861
[patent_doc_number] => 05856363
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Methods of using ajoene'
[patent_app_type] => 1
[patent_app_number] => 8/584052
[patent_app_country] => US
[patent_app_date] => 1996-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3866
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856363.pdf
[firstpage_image] =>[orig_patent_app_number] => 584052
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/584052 | Methods of using ajoene | Jan 10, 1996 | Issued |
| 08/578527 | PHARMACEUTICAL COMPOSITIONS FOR SPARINGLY SOLUBLE THERAPEUTIC AGENTS | Jan 4, 1996 | Abandoned |
Array
(
[id] => 3698199
[patent_doc_number] => 05677291
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-14
[patent_title] => 'Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols'
[patent_app_type] => 1
[patent_app_number] => 8/582835
[patent_app_country] => US
[patent_app_date] => 1996-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6598
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/677/05677291.pdf
[firstpage_image] =>[orig_patent_app_number] => 582835
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/582835 | Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols | Jan 1, 1996 | Issued |
| 08/581394 | COMPOSITIONS COMPRISING NICOTINYLALANINE AND AN INHIBITOR OF GLYCINE CONJUGATION AND THEIR USE FOR REDUCING CELLULAR TOXICITY | Dec 28, 1995 | Abandoned |
Array
(
[id] => 3862183
[patent_doc_number] => 05795896
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'Antithrombotic formulation, process for its manufacturing, and use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/564122
[patent_app_country] => US
[patent_app_date] => 1995-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4636
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795896.pdf
[firstpage_image] =>[orig_patent_app_number] => 564122
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/564122 | Antithrombotic formulation, process for its manufacturing, and use thereof | Dec 17, 1995 | Issued |
Array
(
[id] => 3744227
[patent_doc_number] => 05801177
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-01
[patent_title] => 'Method for controlling and/or lowering serum glucose and fatty acid concentrations and hypertensive blood pressure in non-insulin-dependent diabetic patients'
[patent_app_type] => 1
[patent_app_number] => 8/572743
[patent_app_country] => US
[patent_app_date] => 1995-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4553
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/801/05801177.pdf
[firstpage_image] =>[orig_patent_app_number] => 572743
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/572743 | Method for controlling and/or lowering serum glucose and fatty acid concentrations and hypertensive blood pressure in non-insulin-dependent diabetic patients | Dec 13, 1995 | Issued |
| 08/532681 | PREPARATION FOR THE TREATMENT AND PREVENTION OF DEMENTIA DISORDERS | Dec 7, 1995 | Abandoned |
Array
(
[id] => 3729705
[patent_doc_number] => 05652273
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => 'Reduction of hair growth'
[patent_app_type] => 1
[patent_app_number] => 8/565728
[patent_app_country] => US
[patent_app_date] => 1995-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2590
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/652/05652273.pdf
[firstpage_image] =>[orig_patent_app_number] => 565728
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/565728 | Reduction of hair growth | Nov 29, 1995 | Issued |
Array
(
[id] => 4088243
[patent_doc_number] => 06017963
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-25
[patent_title] => 'Formulation for intranasal administration'
[patent_app_type] => 1
[patent_app_number] => 8/557279
[patent_app_country] => US
[patent_app_date] => 1995-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6529
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/017/06017963.pdf
[firstpage_image] =>[orig_patent_app_number] => 557279
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/557279 | Formulation for intranasal administration | Nov 13, 1995 | Issued |
| 08/548822 | COMPOSITIONS, KITS AND METHODS FOR ADMINISTRATION OF ANTILIPEMIC DRUGS AND FOR INCREASING THE EFFECTIVENESS OF A NONSTEROIDAL ANTI-INFLAMMATORY DRUG FOR ANTI-PLATELET AGGREGATION IN NON-RESPONDING PATIENTS | Oct 25, 1995 | Abandoned |
Array
(
[id] => 3691581
[patent_doc_number] => 05604199
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-18
[patent_title] => 'Method of treating fibrosis in skeletal muscle tissue'
[patent_app_type] => 1
[patent_app_number] => 8/543812
[patent_app_country] => US
[patent_app_date] => 1995-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5142
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/604/05604199.pdf
[firstpage_image] =>[orig_patent_app_number] => 543812
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/543812 | Method of treating fibrosis in skeletal muscle tissue | Oct 15, 1995 | Issued |
Array
(
[id] => 3994635
[patent_doc_number] => 05919806
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-06
[patent_title] => 'Medicines for cardiac insufficiency'
[patent_app_type] => 1
[patent_app_number] => 8/530252
[patent_app_country] => US
[patent_app_date] => 1995-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18385
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 806
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/919/05919806.pdf
[firstpage_image] =>[orig_patent_app_number] => 530252
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/530252 | Medicines for cardiac insufficiency | Sep 28, 1995 | Issued |
Array
(
[id] => 3740521
[patent_doc_number] => 05753632
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Use of colloidal silica for the treatment of sickle-cell anaemia, malaria and exogenously induced leucopenias'
[patent_app_type] => 1
[patent_app_number] => 8/522380
[patent_app_country] => US
[patent_app_date] => 1995-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1490
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753632.pdf
[firstpage_image] =>[orig_patent_app_number] => 522380
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/522380 | Use of colloidal silica for the treatment of sickle-cell anaemia, malaria and exogenously induced leucopenias | Sep 20, 1995 | Issued |
Array
(
[id] => 4045865
[patent_doc_number] => 05912271
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'Pharmaceutical preparation for pain management'
[patent_app_type] => 1
[patent_app_number] => 8/532844
[patent_app_country] => US
[patent_app_date] => 1995-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2120
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/912/05912271.pdf
[firstpage_image] =>[orig_patent_app_number] => 532844
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/532844 | Pharmaceutical preparation for pain management | Sep 17, 1995 | Issued |